AdvisorShares Vice ETF (ACT) Social Stream



AdvisorShares Vice ETF (ACT): $23.49

0.18 (+0.77%)

POWR Rating

Component Grades

Trade

NA

Buy & Hold

NA

Peer

NA

Enact Holdings Inc (ACT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ACT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-16 5 $28 $23 $25.4 $22.29 13.95%
2021-11-17 5 $28 $23.5 $25.5 $22.29 14.4%
2022-02-03 6 $28 $23.5 $25.7 $22.29 15.3%
2022-03-10 6 $28 $24 $26 $22.29 16.64%

ACT reports an average of 15.22% for its upside potential over the past 126 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-04 5 28 23.0 25.4 23.52 7.99%
2021-11-16 5 28 23.0 25.4 23.24 9.29%
2021-11-17 6 28 23.5 25.5 22.95 11.11%
2022-01-19 6 28 23.5 25.7 21.67 18.6%
2022-03-10 6 28 24.0 26.0 20.32 27.95%

ACT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 4 1 1 0 0 6

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ACT has a lower variance in analysts' estimates than 3.2% of all US stocks.
  • In terms of how Enact Holdings Inc fares relative to Insurance stocks, note that its average analyst price target is higher than 101.76% of that group.
  • In terms of how Enact Holdings Inc fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 152.01% of that group.
  • In terms of how Enact Holdings Inc fares relative to Insurance stocks, note that its number of analysts covering the stock is greater than 159.26% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Insurance industry with the ratings most similar to Enact Holdings Inc are TRUP, OSCR, and CLOV.

Is ACT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5718 seconds.